Safety and Immunogenicity of a Monovalent Inactivated Influenza H3N2 Variant (H3N2v) Vaccine in Adult and Elderly Populations

NCT01746082 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

211

Enrollment

NIH

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Influenza A/H3N2 variant Vaccine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)